YC-1 induces lipid droplet formation in RAW 264.7 macrophages

Journal of Biomedical Science
Leo TsuiI-Jong Wang

Abstract

3-(5'-Hydroxymethyl-2'-furyl)-1-benzylindazole (YC-1) is a potential anticancer drug that may activate soluble guanylyl cyclase (sGC) and increase the level of cyclic guanosine monophosphate (cGMP). The aim of this study was to explore the effects of YC-1 on lipid droplet accumulation and foam cell formation in macrophages. Human-oxidized low density lipoprotein (ox-LDL) was used to induce accumulation of lipid droplets in a murine macrophage cell line, RAW 264.7. Oil red O staining showed that treatment with 20 μM YC-1 for 24 h increased the area of intracellular lipid droplets in macrophages. The results of high content screening (HCS) with the AdipoRed™ assay further revealed that YC-1 enhanced ox-LDL-induced foam cell formation. This was evidenced by an increase in the total area of lipid droplets and the mean fluorescence intensity per cell. Inhibition of cGMP-dependent protein kinase (PKG) using KT5823 significantly reduced YC-1-enhanced lipid droplet formation in ox-LDL-induced macrophage foam cells. YC-1 induces lipid droplet formation in macrophages, possibly through the sGC/cGMP/PKG signaling pathway. This chemical should be tested with caution in future clinical trials.

References

May 1, 1991·The Biochemical Journal·J M StewartJ A Berkelaar
Jul 1, 1993·The American Journal of Physiology·J Mattana, P C Singhal
Aug 22, 1997·The Journal of Biological Chemistry·D Steinberg
Mar 10, 2001·Cell·C K Glass, J L Witztum
Jan 25, 2002·Annals of the New York Academy of Sciences·A BoullierJ L Witztum
Nov 2, 2002·Nature Medicine·Andrew C Li, Christopher K Glass
Apr 3, 2003·Journal of the National Cancer Institute·Eun-Jin YeoJong-Wan Park
Aug 18, 2004·Biochemical Pharmacology·Eun-Jin YeoJong-Wan Park
Sep 24, 2005·Current Pharmaceutical Design·Pavel ShashkinKlaus Ley
Dec 3, 2005·Nature Reviews. Immunology·Siamon Gordon, Philip R Taylor
Nov 6, 2009·Antioxidants & Redox Signaling·Irena LevitanPapasani V Subbaiah
Nov 26, 2009·Combinatorial Chemistry & High Throughput Screening·Joseph M Zock
Dec 17, 2009·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Margot Grandl, Gerd Schmitz
Mar 30, 2010·Trends in Biotechnology·Fabian ZanellaWolfgang Link
Aug 19, 2010·Pharmacological Reviews·Sharron H FrancisDavid Sibley
May 3, 2011·Cell·Kathryn J Moore, Ira Tabas
Sep 6, 2011·Trends in Molecular Medicine·James A StefaterJeremy S Duffield
Mar 3, 2012·Toxicology and Applied Pharmacology·Tsong-Long HwangYao-Ching Fang
Apr 27, 2013·Nature·Thomas A WynnJeffrey W Pollard

❮ Previous
Next ❯

Citations

Oct 3, 2018·Nature Reviews. Endocrinology·Frank J GonzalezChangtao Jiang
Nov 25, 2020·Assay and Drug Development Technologies·Leo Tsui, Tsorng-Harn Fong
Jul 5, 2021·Toxicology·Ida FloranceNatarajan Chandrasekaran

❮ Previous
Next ❯

Methods Mentioned

BETA
light microscopy

Software Mentioned

Image
SAS

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.